Search
Atopic Dermatitis Paid Clinical Trials in South Dakota
A listing of 3 Atopic Dermatitis clinical trials in South Dakota actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
The state of South Dakota currently has 3 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Watertown and Aberdeen.
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 12 to 17)
Recruiting
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 12 to 17)
Recruiting
Featured Trial
Moderate to Severe Atopic Dermatitis Study
Recruiting
Conditions:
Atopic Dermatitis
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 18+)
Recruiting
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
06/19/2024
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Atopic Dermatitis
A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe AD
Recruiting
The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneous using devices for injection at home.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
06/05/2024
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Atopic Dermatitis
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Recruiting
This is a phase 2, multi-center, randomized, placebo-controlled, double-blind, parallel-group, dose-ranging study, conducted in subjects with moderate-to-severe atopic dermatitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/04/2022
Locations: AkesoBio Investigative Site 2005, Rapid City, South Dakota
Conditions: Atopic Dermatitis
1 - 3 of 3